Healthcare -
Biotechnology - NASDAQ - US
$ 4.14
-2.62 %
$ 178 M
Market Cap
-6.39
P/E
DMAC - OPERATING INCOME
Operating Income DMAC - DiaMedica Therapeutics Inc.
-26.7 M
LAST VALUE
-38.05%
2 YEAR CAGR
-18.14%
5 YEAR CAGR
-18.63%
10 YEAR CAGR